Buy DuoNeb (Ipratropium / Albuterol) Online
(Ipratropium Bromide / Albuterol (Salbutamol Sulfate))
Brand Name
Generic equivalent for DuoNeb
Ipratropium Bromide / Albuterol (Salbutamol Sulfate) 0.5mg/2.5mg/2.5ml Solution
Prescription required. Can not be split. Product of New Zealand. Shipped from New Zealand.
Introduction
DuoNeb (ipratropium/albuterol) treats bronchospasm associated with chronic obstructive pulmonary disease (COPD). It works by opening and relaxing the airways of the lungs, making it easier to breathe. The drug is a combination of an anticholinergic (ipratropium) and a beta-adrenergic (albuterol) medication. It is often called a “controller medication,” meaning it is often intended to be used on a routine schedule rather than as needed.
To comply with Canadian International Pharmacy Association regulations you are permitted to order a 3-month supply or the closest package size available based on your personal prescription. read more
Storing Medicine
According to the FDA, DuoNeb should be stored between 2°C and 25°C (36°F and 77°F). Vials should be protected from light before using them. Keep unused vials in the foil pouch or carton, which will prevent sunlight from making direct contact. Do not use the vials after the expiration (EXP) date printed on the carton.
Side Effects
Common side effects of DuoNeb (Ipratropium / Albuterol) are some of the following:
Common side effects of DuoNeb:
Chest pain
Cough
Diarrhea
Nausea
Leg cramps
Less common side effects of DuoNeb:
While not reported as commonly, it’s important to talk with your healthcare provider if you experience any of the following:
Blurred vision
Worsening of narrow-angle glaucoma
Eye pain
Worsening of COPD symptoms, including cough and shortness of breath
Elevated or irregular heart rate
Skin rash or hives
Swelling of the face, lips, eyelids, mouth, or throat
Other Information
Does DuoNeb (ipratropium/albuterol) interact with other medicines?
If you’re using any other over-the-counter (OTC) or prescription medications, it’s always advised to inform your primary care physician of these medications in advance.
In particular, it’s important to discuss with your healthcare provider if you are using any of the following before using ipratropium/albuterol.
Any type of inhaled anticholinergic. This would include drugs such as tiotropium (Spiriva Respimat), umeclidinium (Incruse Ellipta), or aclidinium (Tudorza Pressair), which are also commonly used for COPD.
Any type of beta-2 agonist, such as albuterol, levalbuterol (Xopenex HFA), salmeterol (Serevent), arformoterol (Brovana), olodaterol (Striverdi), or formoterol (Perforomist), which are also commonly used for treating asthma or COPD.
Any anticholinergic medicine that you might be on. This includes medications with anticholinergic side effects like antihistamines and medicines commonly used for overactive bladder, Parkinson’s disease, or stomach problems.
Beta-blocker medications, such as metoprolol (Lopressor), atenolol (Tenormin), or propranolol (Inderal LA), are common medicines that may be used for certain heart conditions or to reduce blood pressure. Because they also act at beta receptors, these may interact with albuterol, making either treatment less effective.
Any monoamine oxidase inhibitor (MAOI) used within the past 2 weeks. These are medications usually used to treat depression or Parkinson’s disease.
Any tricyclic antidepressant drug such as amitriptyline, nortriptyline, or protriptyline. Make sure to inform your physician about use within the past 2 weeks, even if it’s not used for depression. These are also commonly used for other purposes ranging from sleep to migraines.
A diuretic medicine, also called a “water pill,” which is a medicine used to reduce edema (fluid retention or swelling) and blood pressure.
The content on this page is for informational and educational purposes only and does not constitute professional medical advice. Patients should not use the information presented on this page for diagnosing a health-related issue or disease. Before taking any medication or supplements, patients should always consult a physician or qualified healthcare professional for medical advice or information about whether a drug is safe, appropriate or effective.
